Ryan Specialty Holdings, Inc. (NYSE:RYAN) Shares Purchased by Invesco Ltd.

Invesco Ltd. lifted its position in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 14.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 718,016 shares of the company's stock after acquiring an additional 88,640 shares during the quarter. Invesco Ltd. owned 0.27% of Ryan Specialty worth $46,068,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of the business. Vanguard Group Inc. lifted its position in shares of Ryan Specialty by 5.7% during the 4th quarter. Vanguard Group Inc. now owns 9,880,504 shares of the company's stock valued at $633,933,000 after buying an additional 529,631 shares in the last quarter. Blair William & Co. IL raised its position in Ryan Specialty by 0.6% during the fourth quarter. Blair William & Co. IL now owns 2,765,963 shares of the company's stock worth $177,464,000 after acquiring an additional 16,540 shares during the period. Principal Financial Group Inc. lifted its holdings in Ryan Specialty by 115.2% during the fourth quarter. Principal Financial Group Inc. now owns 1,833,209 shares of the company's stock valued at $117,619,000 after purchasing an additional 981,505 shares in the last quarter. Geode Capital Management LLC grew its position in shares of Ryan Specialty by 2.7% in the fourth quarter. Geode Capital Management LLC now owns 1,799,130 shares of the company's stock valued at $115,468,000 after purchasing an additional 46,960 shares during the period. Finally, Barclays PLC increased its stake in shares of Ryan Specialty by 1.1% during the third quarter. Barclays PLC now owns 1,641,743 shares of the company's stock worth $108,994,000 after purchasing an additional 17,267 shares in the last quarter. 84.82% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts recently weighed in on RYAN shares. UBS Group raised their price target on shares of Ryan Specialty from $82.00 to $84.00 and gave the company a "buy" rating in a research note on Wednesday, February 26th. Royal Bank of Canada lowered their price target on Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating on the stock in a research note on Friday, February 21st. Wells Fargo & Company reduced their price objective on Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating for the company in a research note on Thursday, April 10th. Keefe, Bruyette & Woods lowered their target price on shares of Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 9th. Finally, Barclays reduced their target price on shares of Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating for the company in a research report on Friday, April 11th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat, the company has an average rating of "Hold" and a consensus price target of $75.67.

Insider Buying and Selling at Ryan Specialty

In related news, EVP Brendan Martin Mulshine sold 30,000 shares of the stock in a transaction dated Friday, March 14th. The stock was sold at an average price of $69.30, for a total transaction of $2,079,000.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $66.35, for a total value of $2,322,250.00. Following the completion of the transaction, the director now directly owns 20,909 shares of the company's stock, valued at approximately $1,387,312.15. This represents a 62.60 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 141,894 shares of company stock worth $9,429,470 over the last three months. Insiders own 11.10% of the company's stock.

Ryan Specialty Trading Down 2.0 %

Shares of RYAN traded down $1.46 during mid-day trading on Friday, reaching $70.63. The stock had a trading volume of 967,494 shares, compared to its average volume of 943,985. Ryan Specialty Holdings, Inc. has a 52-week low of $48.48 and a 52-week high of $77.16. The firm has a market cap of $18.50 billion, a price-to-earnings ratio of 102.37, a P/E/G ratio of 1.19 and a beta of 0.66. The business's fifty day moving average is $70.46 and its 200 day moving average is $69.03. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01.

Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its earnings results on Thursday, February 20th. The company reported $0.45 EPS for the quarter, missing analysts' consensus estimates of $0.47 by ($0.02). The business had revenue of $663.53 million during the quarter, compared to analysts' expectations of $658.80 million. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. On average, sell-side analysts predict that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current fiscal year.

Ryan Specialty Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Tuesday, March 4th were given a $0.12 dividend. The ex-dividend date of this dividend was Tuesday, March 4th. This represents a $0.48 dividend on an annualized basis and a yield of 0.68%. This is a boost from Ryan Specialty's previous quarterly dividend of $0.11. Ryan Specialty's dividend payout ratio is presently 69.57%.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.